News Conference News ACC 2026 Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b Yael L. Maxwell April 01, 2026
News Conference News ACC 2026 Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering Michael O'Riordan April 01, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2026 Caitlin E. Cox April 01, 2026
News Conference News ACC 2026 GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’ L.A. McKeown March 31, 2026
News Conference News ACC 2026 SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients Michael O'Riordan March 30, 2026
News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Barbershop Effort Falls Short for Hypertension Prevention in Black Men Todd Neale March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Conference News ACC 2026 KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension Caitlin E. Cox March 28, 2026
News Daily News Genomics, Lipids, Inflammation at Midlife Predict Future CAD Caitlin E. Cox March 25, 2026
News Daily News Several Factors Linked to Subsequent Events After TIA, Minor Stroke Todd Neale March 23, 2026
News Daily News Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race L.A. McKeown March 23, 2026
News Daily News Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1 Caitlin E. Cox March 19, 2026
News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide L.A. McKeown March 19, 2026
News Daily News Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk Yael L. Maxwell March 19, 2026
News Conference News CRT 2026 PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years L.A. McKeown March 17, 2026
News Daily News Ultraprocessed Food Again Linked to Higher CVD Risk: MESA Michael O'Riordan March 17, 2026
News Daily News Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA Yael L. Maxwell March 16, 2026